Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

Juergen Braun,Hildrun Haibel,M. de Hooge,R. Landewé,Martin Rudwaleit,Todd Fox,Aimee Readie,Hanno Richards,Brian Porter,Ruvie Martin,Denis Poddubnyy,J. Sieper,D. van der Heijde

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

2019

Juergen Braun
Hildrun Haibel
M. de Hooge
R. Landewé
Martin Rudwaleit
Todd Fox
Aimee Readie
Hanno Richards
Brian Porter
Ruvie Martin
Denis Poddubnyy
J. Sieper
D. van der Heijde

Objective The aim of this study was to compare radiographic progression in patients with ankylosing spondylitis (AS) treated for up to 2 years with secukinumab (MEASURE 1) with a historical cohort of biologic-naive patients treated with NSAIDs (ENRADAS).

Keywords:

Diabetes mellitus
Immunology
Radiography
Medicine
Internal medicine
Secukinumab
Ankylosing spondylitis
Historical Cohort
Retrospective cohort study
Interleukin 17
Rheumatology
Cohort
Orthopedic surgery
Clinical endpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations